Upstate Active Clinical Trials Seeking Participants
Cancer Clinical Trials
22 trials found. Please click on the number above the trial title to find more information about a trial.
A Phase I/II Study in Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer.
A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer (NSABP B-39 / RTOG 0413)
A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy
Allogeneic Hematopoietic Stem Cell Transplanation for CLL, CML, AML, ALL, Myelodysplasia and Non-Hodgkin?s Lymphoma after Total Body Irradiation and Cyclophosphamide Conditioning or Cyclophosphamide and ATG Conditioning For Aplastic Anemia.
Allogeneic Peripheral Blood Stem Cell Transplant Utilizing Non-Myeloablative Conditioning Therapy. A Phase II Study.
Autologous Hematopoietic Stem Cell and/or Bone Marrow Transplantation after High Dose Chemotherapy (Carboplatinum, Etoposide) in Patients with Recurrent/Refractory Germ Cell Tumors
Autologous Hematopoietic Stem Cell Transplantation After Melphalan with or without Total Body Irradiation for Multiple Myeloma.
Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First or Second Remission.
CALGB 30607: Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511, IND #74019) as Maintenance Therapy in Non-Progressing Patients following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB/IV Non-Small Cell Lung Cancer
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Recieving Cisplatan and Etopside.
A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Phase III Randomized Study of Sorafenib (IND 69896, NSC 724772) Plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC)
CALGB 90203:Randomized Phase III Study of Neo-adjuvant Docetaxel and Androgen Deprivation prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
ECOG E1505:A Phase III Randomized Trial of Adjuvant Chemotherapy with or Without Bevacizumab for Patients with Completely Resected Stage IB (> 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)
High Dose Cyclophosphamide, BCNU, Etoposide & Autologous Hematopoietic Stem Cell Transplantation for Resistant & Relapsed Hodgkin's Disease.
High Dose Cyclophosphamide, Thiotepa & Etoposide Followed by Autologous Hematopoietic Stem Cell Transplantation (Intermediate & High Grade).
Study Drug Versus Other Chemotherapeutic Agents For Third-Line Single Agent Treatment of Patients With Relapsed Aggressive Non-Hodgkin?s Lymphoma: A Randomized, Controlled, Phase III Comparative Trial.
Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
Randomized Phase III Trial Comparing Everolimus Plus Placebo Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment with Tyrosine Kinase Inhibitors
S0424: Molecular Epidemiology Case Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Study Title: Z6051: A Phase III Prospective Randomized Trial Comparing Laparoscopic-assisted Resection Versus Open Resection for Rectal Cancer